Literature DB >> 22694307

Distinct and overlapping functional roles of Src family kinases in mouse platelets.

S Séverin1, C A Nash, J Mori, Y Zhao, C Abram, C A Lowell, Y A Senis, S P Watson.   

Abstract

BACKGROUND AND OBJECTIVES: Src family kinases (SFKs) play a critical role in initiating and propagating signals in platelets. The aims of this study were to quantitate SFK members present in platelets and to analyze their contribution to platelet regulation using glycoprotein VI (GPVI) and intregrin αIIbβ3, and in vivo. METHODS AND
RESULTS: Mouse platelets express four SFKs, Fgr, Fyn, Lyn and Src, with Lyn expressed at a considerably higher level than the others. Using mutant mouse models, we demonstrate that platelet activation by collagen-related peptide (CRP) is delayed and then potentiated in the absence of Lyn, but only marginally reduced in the absence of Fyn or Fgr, and unaltered in the absence of Src. Compound deletions of Lyn/Src or Fyn/Lyn, but not of Fyn/Src or Fgr/Lyn, exhibit a greater delay in activation relative to Lyn-deficient platelets. Fibrinogen-adherent platelets show reduced spreading in the absence of Src, potentiation in the absence of Lyn, but no change in the absence of Fyn or Fgr. In mice double-deficient in Lyn/Src or Fgr/Lyn, the inhibitory role of Lyn on spreading on fibrinogen is lost. Lyn is the major SFK-mediating platelet aggregation on collagen at arterial shear and its absence leads to a reduction in thrombus size in a laser injury model.
CONCLUSION: These results demonstrate that SFKs share individual and overlapping roles in regulating platelet activation, with Lyn having a dual role in regulating GPVI signaling and an inhibitory role downstream of αIIbβ3, which requires prior signaling through Src.
© 2012 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22694307      PMCID: PMC4280098          DOI: 10.1111/j.1538-7836.2012.04814.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  61 in total

1.  Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain.

Authors:  Izumi Sato; Yuuki Obata; Kousuke Kasahara; Yuji Nakayama; Yasunori Fukumoto; Takahito Yamasaki; Kazunari K Yokoyama; Takashi Saito; Naoto Yamaguchi
Journal:  J Cell Sci       Date:  2009-03-03       Impact factor: 5.285

Review 2.  Src-related protein tyrosine kinases in hematopoiesis.

Authors:  S J Corey; S M Anderson
Journal:  Blood       Date:  1999-01-01       Impact factor: 22.113

3.  Lyn and PECAM-1 function as interdependent inhibitors of platelet aggregation.

Authors:  Zhangyin Ming; Yu Hu; Jizhou Xiang; Peter Polewski; Peter J Newman; Debra K Newman
Journal:  Blood       Date:  2011-02-04       Impact factor: 22.113

4.  Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes.

Authors:  Jesse W Rowley; Andrew J Oler; Neal D Tolley; Benjamin N Hunter; Elizabeth N Low; David A Nix; Christian C Yost; Guy A Zimmerman; Andrew S Weyrich
Journal:  Blood       Date:  2011-05-19       Impact factor: 22.113

5.  The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo.

Authors:  Marie-Pierre Gratacap; Valérie Martin; Marie-Cécile Valéra; Sophie Allart; Cédric Garcia; Pierre Sié; Christian Recher; Bernard Payrastre
Journal:  Blood       Date:  2009-06-03       Impact factor: 22.113

6.  Lyn, PKC-delta, SHIP-1 interactions regulate GPVI-mediated platelet-dense granule secretion.

Authors:  Ramya Chari; Soochong Kim; Swaminathan Murugappan; Archana Sanjay; James L Daniel; Satya P Kunapuli
Journal:  Blood       Date:  2009-07-08       Impact factor: 22.113

7.  Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets.

Authors:  Brian Boylan; Cunji Gao; Vipul Rathore; Joan C Gill; Debra K Newman; Peter J Newman
Journal:  Blood       Date:  2008-07-18       Impact factor: 22.113

8.  Src family tyrosine kinase Lyn mediates VWF/GPIb-IX-induced platelet activation via the cGMP signaling pathway.

Authors:  Hong Yin; Junling Liu; Zhenyu Li; Michael C Berndt; Clifford A Lowell; Xiaoping Du
Journal:  Blood       Date:  2008-06-11       Impact factor: 22.113

9.  Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor gamma chain complex on human platelets.

Authors:  Y Ezumi; K Shindoh; M Tsuji; H Takayama
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

10.  The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis.

Authors:  Yotis A Senis; Michael G Tomlinson; Stuart Ellison; Alexandra Mazharian; Jenson Lim; Yan Zhao; Kristin N Kornerup; Jocelyn M Auger; Steve G Thomas; Tarvinder Dhanjal; Neena Kalia; Jing W Zhu; Arthur Weiss; Steve P Watson
Journal:  Blood       Date:  2009-02-25       Impact factor: 22.113

View more
  24 in total

1.  Maintenance of murine platelet homeostasis by the kinase Csk and phosphatase CD148.

Authors:  Jun Mori; Zoltan Nagy; Giada Di Nunzio; Christopher W Smith; Mitchell J Geer; Rashid Al Ghaithi; Johanna P van Geffen; Silke Heising; Luke Boothman; Bibian M E Tullemans; Joao N Correia; Louise Tee; Marijke J E Kuijpers; Paul Harrison; Johan W M Heemskerk; Gavin E Jarvis; Alexander Tarakhovsky; Arthur Weiss; Alexandra Mazharian; Yotis A Senis
Journal:  Blood       Date:  2018-01-04       Impact factor: 22.113

2.  Involvement of the HCK and FGR src-family kinases in FCRL4-mediated immune regulation.

Authors:  Yanling Liu; Ksenia Bezverbnaya; Tiantian Zhao; Marion J Parsons; Mengyao Shi; Bebhinn Treanor; Götz R A Ehrhardt
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

3.  Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice.

Authors:  Zoltan Nagy; Jun Mori; Vanesa-Sindi Ivanova; Alexandra Mazharian; Yotis A Senis
Journal:  Blood       Date:  2020-04-30       Impact factor: 22.113

4.  Soluble GPVI is elevated in injured patients: shedding is mediated by fibrin activation of GPVI.

Authors:  Samantha J Montague; Céline Delierneux; Christelle Lecut; Nathalie Layios; Robert J Dinsdale; Christine S-M Lee; Natalie S Poulter; Robert K Andrews; Peter Hampson; Christopher M Wearn; Nathalie Maes; Jonathan Bishop; Amy Bamford; Chris Gardiner; Woei Ming Lee; Tariq Iqbal; Naiem Moiemen; Steve P Watson; Cécile Oury; Paul Harrison; Elizabeth E Gardiner
Journal:  Blood Adv       Date:  2018-02-13

Review 5.  Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity.

Authors:  Yacine Boulaftali; Paul R Hess; Mark L Kahn; Wolfgang Bergmeier
Journal:  Circ Res       Date:  2014-03-28       Impact factor: 17.367

6.  The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear.

Authors:  Cassandra P Loren; Joseph E Aslan; Rachel A Rigg; Marie S Nowak; Laura D Healy; András Gruber; Brian J Druker; Owen J T McCarty
Journal:  Thromb Res       Date:  2014-11-18       Impact factor: 3.944

7.  Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activation.

Authors:  Joanne L Dunster; Amanda J Unsworth; Alexander P Bye; Elizabeth J Haining; Marcin A Sowa; Ying Di; Tanya Sage; Chiara Pallini; Jeremy A Pike; Alexander T Hardy; Bernhard Nieswandt; Ángel García; Steve P Watson; Natalie S Poulter; Jonathan M Gibbins; Alice Y Pollitt
Journal:  J Thromb Haemost       Date:  2019-12-06       Impact factor: 5.824

Review 8.  Integrin αIIbβ3 outside-in signaling.

Authors:  Tom N Durrant; Marion T van den Bosch; Ingeborg Hers
Journal:  Blood       Date:  2017-08-09       Impact factor: 22.113

9.  Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet function.

Authors:  Rachel A Rigg; Joseph E Aslan; Laura D Healy; Michael Wallisch; Marisa L D Thierheimer; Cassandra P Loren; Jiaqing Pang; Monica T Hinds; András Gruber; Owen J T McCarty
Journal:  Am J Physiol Cell Physiol       Date:  2015-12-09       Impact factor: 4.249

10.  Thymidine phosphorylase participates in platelet signaling and promotes thrombosis.

Authors:  Wei Li; Alba Gigante; Maria-Jesus Perez-Perez; Hong Yue; Michio Hirano; Thomas M McIntyre; Roy L Silverstein
Journal:  Circ Res       Date:  2014-10-06       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.